Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06284317
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-05
First Post:
2024-02-21
Brief Title:
A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy Durvalumab and Surgery in Patients with Early-stage Operable Non-small Cell Lung Cancer
Sponsor:
ETOP IBCSG Partners Foundation
Organization:
ETOP IBCSG Partners Foundation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-03
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-21
First Submit QC Date:
February 21 2024
Study First Post Date:
2024-02-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-01
Last Update Post Date:
2024-04-05
Last Update Post Date Type:
ACTUAL